AzTrials
AzTrials

Postoperative CareSMARTERNCT04341558

Family SuppleMented pAtient monitoRing afTEr suRgery: A Pilot Trial

A study testing Family supplemented patient monitoring in people with Postoperative Care and Vital Signs, run by Queen Mary University of London at 1 site in Uganda.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To develop an intervention to train family carers to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff. Read more about this study

Who is it for?
Ages 5 years and older
Conditions the study is for
Postoperative Care, Vital Signs
What is being tested?
Family supplemented patient monitoring
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,395 participants
Where
1 siteUganda
Study dates
13 Apr 2021to 12 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients:
  • Patients ≥5 years of age undergoing surgery at Mbale Regional Referral Hospital, who receive post-operative care in one of four main surgical wards, with a family carer prepared to participate in the trial intervention.
  • Carers:
  • All carers will be included in the trial if they feel they are capable of performing and documenting the basic vital signs provided they agree to participate in the trial.
  • The ability to speak English, Luganda, Lugisu, Ateso or Lugwere
  • The ability to read a digital clock (to measure vital signs)
  • Numeracy sufficient to write numbers on the basic observation chart

Who cannot join

  • Patients:
  • Refusal of informed consent.
  • Identification of potential participant >24hours after operative procedure has taken place
  • Carers:
  • Refusal of informed consent.

Trial locations and contacts

1 site in 1 country.

Uganda1 site
  • Mbale Regional Referral Hospital

    Mbale

Other trials in Uganda

About this study

To develop an intervention to train family carers to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff. To evaluate the effect of this intervention on the frequency of documented vital signs for patients in the first three days after surgery in a stepped-wedge cluster trial.

Read the detailed description

Quality improvement (QI) interventions can be seen has having a 'hard core', the clinical processes or practices that are the focus of improvement, and a 'soft periphery', the improvement methods that will enable change to occur. In the SMARTER trial, family carers will be trained to perform basic vital signs monitoring and document the results. Nursing and medical teams looking after patients on the wards will retain full responsibility for patient care throughout all phases of the trial. The nursing team will be provided with an identical observation chart for all their ward patients at the beginning of the trial and will be given training on how to use them and how to respond to deteriorating vital signs.

During the intervention period, in addition to the nurses' vital signs monitoring, family members will be asked to perform basic vital signs monitoring. Participants will be given clear guidance on when to alert staff to potential danger signs.

The soft periphery is the training programme and resources designed to assist staff to rapidly and effectively train these skills combined with ongoing maintenance strategies to ensure the compliance with the intervention is maintained throughout the intervention period. The investigators will use the Medical Research Council (MRC) Complex Intervention framework to guide the development and evaluation of our intervention. Previous empirical work on task-sharing and relevant theory will be used to design the intervention and associated programme theory (Phase 1 of the MRC framework), with an iterative co-design process used to further develop these and test how the intervention works in practice (Phase 2).

Intervention training sessions will last 30 minutes and will be held twice a day over a period of six months. Participants will be welcome to attend as often as they wish. Participants will be given practical training to assess the following vital signs: heart rate, respiratory rate, conscious level (AVPU scale) and arterial oxygen saturation (SpO2) in accordance with trial standard operating procedures. An important component of the training package will be ensuring participants know how to wash their hands before and after contact with their patients. The investigators will ensure that handwashing facilities are available on the ward for use by participants. Participants will record vital signs on a basic observation chart every 4 hours after surgery. They will compare results with colour posters displayed throughout each ward, providing guidance on how and when to notify nursing staff of abnormal vital signs.

Participants will have access to the following equipment throughout the trial: pulse oximeter, wall clock, colour coded guidelines on wall, observation charts, clipboard and pen. Although poor numeracy and literacy are common in eastern Uganda, most patients will have a carer who is able to read a digital clock and write numbers. The observation chart will be designed to be very simple to use. Participants will be encouraged to attend the training sessions each day to ensure their skills and knowledge are refreshed. After the third post-operative day, the trial intervention will end although participants may choose to continue monitoring vital signs and attending training sessions if they wish. It is acknowledged that carers may have to change throughout the day due to conflicting family or work commitments. Participants will be encouraged to remain available to monitor their patients for the duration of the study period (72 hours). Medical and nursing staff on the wards will undergo training in how to respond appropriately to abnormal vital signs.

Being tested
Family supplemented patient monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family supplemented patient monitoringOther

    Intervention training sessions will last 30 minutes and will be held twice a day over a period of six months. Carers will be welcome to attend as often as they wish. Carers will be given practical training to assess the following vital signs: heart rate, respiratory rate, conscious level (AVPU scale) and arterial oxygen saturation (SpO2) in accordance with trial standard operating procedures. An important component of the training package will be ensuring carers know how to wash their hands before and after contact with their patients. The study team will ensure that handwashing facilities are available on the ward for use by carers. Carers will record vital signs on a basic observation chart every 4 hours after surgery. They will compare results with colour posters displayed throughout each ward, providing guidance on how and when to notify nursing staff of abnormal vital signs.

Study groups in NCT04341558
Study groupRoleWhat they receive
BaselineNo interventionDuring this baseline period, postoperative monitoring will be continued as normal by nursing and medical staff without intervention. No training of family members will take place
InterventionActive comparatorFamily carers will be trained to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff.
Receives: Other: Family supplemented patient monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frequency of documented vital signs for patients after surgery

    To develop a training and support intervention, in accordance with the MRC complex intervention framework, to train family carers to perform and document basic vital signs, to supplement routine monitoring of patients by nursing staff, whilst they provide personal care to their relatives after surgery and to evaluate the effect of this intervention on frequency of documented vital signs for patients in the first three days after surgery in a stepped-wedge cluster trial (explanatory outcome).

    Measured: 72 hours

Secondary outcomes (2)
  1. Duration of hospital stay

    To evaluate the impact of the intervention on the duration of patients' length of hospital stay

    Measured: 30 days

  2. All cause mortality at 30 days

    To evaluate the effect of the intervention on in-patient mortality, to inform the design of a subsequent international clinical trial across Africa

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2020
  2. Study start13 Apr 2021
  3. Primary completion12 Oct 2021
  4. Study completion12 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Model description
Single-centre stepped-wedge cluster randomised trial conducted in four surgical wards over a six-month period
Masking
None (open label)
Enrolment
1,395 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04341558
Sponsor's protocol ID
QMERC2019/72
Acronym
SMARTER
Status last verified
Feb 2022
First submitted
7 Apr 2020
Last updated
9 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hewitt-Smith A, Bulamba F, Patel A, Nanimambi J, Adong LR, Emacu B, Kabaleta M, Khanyalano J, Maiga AH, Mugume C, Nakibuule J, Nandyose L, Sejja M, Weere W, Stephens T, Pearse RM. Family supplemented patient monitoring after surgery (SMARTER): a pilot stepped-wedge cluster-randomised trial. Br J Anaesth. 2024 Oct;133(4):846-852. doi: 10.1016/j.bja.2024.06.027. Epub 2024 Jul 27.

    PubMed 39069451

Questions about this trial

What is this clinical trial studying?

A study testing Family supplemented patient monitoring in people with Postoperative Care and Vital Signs, run by Queen Mary University of London at 1 site in Uganda.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frequency of documented vital signs for patients after surgery (time frame: 72 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04341558, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in